血液瘤中的BET:免疫力,致病性,临床试验和药物组合
Tao Ma1,2, Yan Chen1, Zhi-Gang Yi2
1Department of Hematology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China.
Genes & diseases
|August 9, 2023
概括
勃罗莫达因和外终端 (BET) 抑制剂通过调节细胞过程和免疫反应来治疗血液瘤有望. 未来的研究将探索将BET抑制剂与其他药物结合起来,以提高治疗疗效.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 基因和额外终端 (BET) 蛋白质通过识别 lysine 乙化来调节基因转录,细胞循环和细胞亡.
- BET蛋白与各种癌症的发病有关,包括血液性恶性瘤.
- BET抑制剂 (BETi) 调节免疫检查点,免疫细胞和细胞因子的产生,表明治疗潜力.
研究的目的:
- 审查了解血液瘤中BET蛋白和BET抑制剂的最新进展.
- 总结来自细胞研究,动物模型和临床试验的发现.
- 探索涉及BET抑制剂的药物组合的潜力.
主要方法:
- 在血液瘤中研究BET蛋白和BET抑制剂的文献综述.
- 对研究的分析侧重于细胞机制,体内模型和临床试验结果.
- 对与BET抑制剂联合治疗的数据的检查.
主要成果:
- BET蛋白在c-MYC和BCL-2等瘤基因的转录调节中发挥着至关重要的作用.
- BET抑制剂对与癌症相关的免疫反应产生调节作用.
- 临床前和临床研究的证据支持BET抑制剂在白血病,淋巴瘤和多发性骨髓瘤中的疗效.
结论:
- BET 抑制剂代表了血液瘤的一个有前途的治疗策略.
- 涉及BET抑制剂的组合疗法可能会改善治疗结果.
- 需要进一步的研究来优化基于BET抑制剂的治疗方案.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Bone Marrow Sampling and Transplants
360
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
360
Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557
Hematopoiesis
5.4K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.4K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K


